Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
3.005
-0.065 (-2.12%)
May 6, 2026, 12:10 PM EDT - Market open
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $71.25 million as of May 6, 2026. Its market cap has decreased by -56.41% in one year.
Market Cap
71.25M
Enterprise Value
59.64M
1-Year Change
-56.41%
Ranking
Category
Stock Price
$3.01
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $71.25M, a decrease of -53.16%. That is a compound annual growth rate of -35.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 72.79M | -48.83% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMV Pharmaceuticals | 74.66M |
| TScan Therapeutics | 74.53M |
| Filana Therapeutics | 72.92M |
| Annovis Bio | 71.83M |
| OS Therapies | 71.46M |
| Rallybio | 70.04M |
| MediciNova | 68.91M |
| Estrella Immunopharma | 68.26M |